Corvus Pharmaceuticals, Inc. (CRVS)
NASDAQ: CRVS · Real-Time Price · USD
9.40
-0.65 (-6.47%)
Oct 13, 2026, 4:00 PM EDT - Market closed
Corvus Pharmaceuticals Market Cap
Corvus Pharmaceuticals has a market cap or net worth of $790.74 million as of October 13, 2026. It is the 11,228th most valuable company in the world and the 2,360th biggest in the United States. Its market cap has increased by 51.60% in one year.
Market Cap
790.74M
Enterprise Value
576.24M
1-Year Change
51.60%
Global Rank
Country Rank
#2,360 United States
Category
ChartMarket Cap Chart
Since March 23, 2016, Corvus Pharmaceuticals's market cap has increased from $290.80M to $790.74M, an increase of 171.92%. That is a compound annual growth rate of 9.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 885.00M | 53.89% |
| Dec 31, 2025 | 575.10M | 67.28% |
| Dec 31, 2024 | 343.80M | 298.38% |
| Dec 29, 2023 | 86.30M | 117.93% |
| Dec 30, 2022 | 39.60M | -64.71% |
| Dec 31, 2021 | 112.20M | 12.31% |
| Dec 31, 2020 | 99.90M | -37.56% |
| Dec 31, 2019 | 160.00M | 48.84% |
| Dec 31, 2018 | 107.50M | -50.69% |
| Dec 29, 2017 | 218.00M | -27.09% |
| Dec 30, 2016 | 299.00M | 2.82% |
| Mar 23, 2016 | 290.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alumis | 926.76M |
| MoonLake Immunotherapeutics | 920.85M |
| Rigel Pharmaceuticals | 916.81M |
| Jade Biosciences | 915.17M |
| Odyssey Therapeutics | 910.45M |
| Monte Rosa Therapeutics | 878.73M |
| Ginkgo Bioworks Holdings | 875.42M |
| Helus Pharma | 862.11M |